329 related articles for article (PubMed ID: 10321735)
41. Rac1 and extracellularly regulated kinase activation are sufficient for E1A-dependent cooperative transformation of primary epithelial cells, but progression can only be modulated by E1A or Rac1.
Fischer RS; Zheng Y; Quinlan MP
Cell Growth Differ; 1998 Mar; 9(3):209-21. PubMed ID: 9543387
[TBL] [Abstract][Full Text] [Related]
42. Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation.
Graham SM; Cox AD; Drivas G; Rush MG; D'Eustachio P; Der CJ
Mol Cell Biol; 1994 Jun; 14(6):4108-15. PubMed ID: 8196649
[TBL] [Abstract][Full Text] [Related]
43. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
Khosravi-Far R; White MA; Westwick JK; Solski PA; Chrzanowska-Wodnicka M; Van Aelst L; Wigler MH; Der CJ
Mol Cell Biol; 1996 Jul; 16(7):3923-33. PubMed ID: 8668210
[TBL] [Abstract][Full Text] [Related]
44. SCH 51344-induced reversal of RAS-transformation is accompanied by the specific inhibition of the RAS and RAC-dependent cell morphology pathway.
Walsh AB; Dhanasekaran M; Bar-Sagi D; Kumar CC
Oncogene; 1997 Nov; 15(21):2553-60. PubMed ID: 9399643
[TBL] [Abstract][Full Text] [Related]
45. Suppression of serum-induced c-jun expression by activated Ki-ras in human colon cancer cells.
Furuse M; Shirasawa S; Okumura K; Ohmori M; Sasazuki T
Jpn J Hum Genet; 1997 Sep; 42(3):409-16. PubMed ID: 12503187
[TBL] [Abstract][Full Text] [Related]
46. Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation.
Pruitt K; Pruitt WM; Bilter GK; Westwick JK; Der CJ
J Biol Chem; 2002 Aug; 277(35):31808-17. PubMed ID: 12082106
[TBL] [Abstract][Full Text] [Related]
47. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation.
Khosravi-Far R; Solski PA; Clark GJ; Kinch MS; Der CJ
Mol Cell Biol; 1995 Nov; 15(11):6443-53. PubMed ID: 7565796
[TBL] [Abstract][Full Text] [Related]
48. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
Warne PH; Viciana PR; Downward J
Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
[TBL] [Abstract][Full Text] [Related]
49. The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor.
López-Barahona M; Bustelo XR; Barbacid M
Oncogene; 1996 Feb; 12(3):463-70. PubMed ID: 8637701
[TBL] [Abstract][Full Text] [Related]
50. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation.
Mason CS; Springer CJ; Cooper RG; Superti-Furga G; Marshall CJ; Marais R
EMBO J; 1999 Apr; 18(8):2137-48. PubMed ID: 10205168
[TBL] [Abstract][Full Text] [Related]
51. v-Ras and v-Raf block differentiation of transformable C3H10T1/2-derived preadipocytes at lower levels than required for neoplastic transformation.
Raptis L; Brownell HL; Lu Y; Preston T; Narsimhan RP; Anderson S; Schaefer E; Haliotis T
Exp Cell Res; 1997 Aug; 235(1):188-97. PubMed ID: 9281368
[TBL] [Abstract][Full Text] [Related]
52. M-Ras/R-Ras3, a transforming ras protein regulated by Sos1, GRF1, and p120 Ras GTPase-activating protein, interacts with the putative Ras effector AF6.
Quilliam LA; Castro AF; Rogers-Graham KS; Martin CB; Der CJ; Bi C
J Biol Chem; 1999 Aug; 274(34):23850-7. PubMed ID: 10446149
[TBL] [Abstract][Full Text] [Related]
53. Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation.
Matsubara K; Kishida S; Matsuura Y; Kitayama H; Noda M; Kikuchi A
Oncogene; 1999 Feb; 18(6):1303-12. PubMed ID: 10022812
[TBL] [Abstract][Full Text] [Related]
54. [ras p21-like small MW GTP-binding proteins in transmembrane signaling].
Takai Y; Kikuchi A
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):499-508. PubMed ID: 2495774
[TBL] [Abstract][Full Text] [Related]
55. Mutations that abolish the ability of Ha-Ras to associate with Raf-1.
Shirouzu M; Koide H; Fujita-Yoshigaki J; Oshio H; Toyama Y; Yamasaki K; Fuhrman SA; Villafranca E; Kaziro Y; Yokoyama S
Oncogene; 1994 Aug; 9(8):2153-7. PubMed ID: 8036000
[TBL] [Abstract][Full Text] [Related]
56. A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line.
Huang Y; Saez R; Chao L; Santos E; Aaronson SA; Chan AM
Oncogene; 1995 Oct; 11(7):1255-60. PubMed ID: 7478545
[TBL] [Abstract][Full Text] [Related]
57. Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis.
Ramocki MB; Johnson SE; White MA; Ashendel CL; Konieczny SF; Taparowsky EJ
Mol Cell Biol; 1997 Jul; 17(7):3547-55. PubMed ID: 9199290
[TBL] [Abstract][Full Text] [Related]
58. Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene.
Li Y; White R
Cancer Res; 1996 Jun; 56(12):2872-6. PubMed ID: 8665528
[TBL] [Abstract][Full Text] [Related]
59. Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts.
Tang Y; Yu J; Field J
Mol Cell Biol; 1999 Mar; 19(3):1881-91. PubMed ID: 10022875
[TBL] [Abstract][Full Text] [Related]
60. Isolation of a new protein factor required for activation of Raf-1 by Ha-Ras: partial purification from rat brain cytosols.
Mizutani S; Koide H; Kaziro Y
Oncogene; 1998 May; 16(21):2781-6. PubMed ID: 9652745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
